2025
SJR Q1
JCR Q1 · 13,8
2 eşleşen makale
SCIE
Dergi ayrıntısı
Molecular Aspects of Medicine
- Yayıncı
- Elsevier Ltd
- Ülke
- United Kingdom · Western Europe
- Tür
- journal
- ISSN
-
0098299718729452
Bütünleşik değerlendirme
Scopus tarafı Scimago SJR; WoS tarafı Master Journal List + JCR/JIF. Kaynaklar ISSN üzerinden eşleştirilir. WoS / JCR metrikleri yalnızca 1997 ve sonrası yıllar için vardır.
WoS / JCR verileri 1997 ve sonrası içindir.
Scopus
Scopus · Scimago
- SJR 3,427
- Quartile Q1
- H-Index 176
- Atıf/yayın 13,13
- Doküman (3y) 175
- Atıf (3y) 2.251
Clarivate
Web of Science · JCR · 2025
- JCR Q Q1
- JIF 13,8
- 5Y JIF 13,4
- JCI 1,24
WoS indeksleri
- SCIE
Konu sınıflandırması
Kategoriler (SJR)
- Biochemistry Q1
- Clinical Biochemistry Q1
- Medicine (miscellaneous) Q1
- Molecular Biology Q1
- Molecular Medicine Q1
Alanlar
- Biochemistry, Genetics and Molecular Biology
- Medicine
WoS kategorileri
- Biochemistry & Molecular Biology | Medicine, Research & Experimental
Yıllık quartile karşılaştırması
Scimago (SJR) tüm yıllar; Clarivate (JCR / JIF / JCI) 1997 ve sonrası. Güncel yıl açık; diğer yıllar kapalıdır.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q1 | Q1 | 3,427 | 13,8 | 13,4 | 1,24 | Q1 | 176 |
| 2024 | Q1 | Q1 | 2,947 | 10,3 | 13,1 | 1,22 | Q1 | 168 |
| 2023 | Q1 | Q1 | 2,748 | 8,7 | 13 | 1,31 | Q1 | 168 |
| 2022 | Q1 | Q1 | 3,244 | 10,6 | 13,6 | 1,52 | Q1 | 168 |
| 2021 | Q1 | Q1 | 3,226 | 16,3 | 14,3 | 1,66 | Q1 | 168 |
| 2020 | Q1 | Q1 | 3,492 | 14,2 | 12,3 | 1,68 | Q1 | 168 |
| 2019 | Q1 | Q1 | 3,07 | 9,6 | 9,1 | 1,64 | Q1 | 168 |
| 2018 | — | Q1 | — | 8,3 | 10,3 | 1,34 | Q1 | — |
| 2017 | Q1 | Q1 | 2,819 | 7,3 | 11,1 | 1,32 | Q1 | 168 |
| 2016 | Q1 | Q1 | 5,308 | 5,7 | 10,8 | — | — | 168 |
| 2015 | Q1 | Q1 | 6,382 | 10,9 | 10,7 | — | — | 168 |
| 2014 | Q1 | Q1 | 5,402 | 10,2 | 11 | — | — | 168 |
| 2013 | Q1 | Q1 | 3,9 | 10,3 | 11,2 | — | — | 168 |
| 2012 | Q1 | Q1 | 5,703 | 10,4 | 10,8 | — | — | 168 |
| 2011 | Q1 | Q1 | 3,954 | 10 | 10,3 | — | — | 168 |
| 2010 | Q1 | Q1 | 3,689 | 10,6 | 10,5 | — | — | 168 |
| 2009 | — | Q1 | — | 6,5 | — | — | — | — |
| 2008 | — | Q1 | — | 7,3 | — | — | — | — |
| 2007 | — | Q1 | — | 7,4 | — | — | — | — |
| 1998 | — | Q3 | — | 0,6 | — | — | — | — |
| 1997 | — | Q2 | — | 2 | — | — | — | — |
JCR kategori quartile geçmişi
Yıla ve kategoriye göre JCR / JCI quartile. 1997 ve sonrası.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | Kategori | Edition | JCR Q (1997+) | JCI Q (1997+) | Sıra |
|---|---|---|---|---|---|
| 2025 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q1 | Q1 | 17/328 |
| 2025 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | Q1 | 13/191 |
| 2024 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q1 | Q1 | 21/320 |
| 2024 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | Q1 | 17/195 |
| 2023 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q1 | Q1 | 29/313 |
| 2023 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | Q1 | 17/189 |
| 2022 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q1 | Q1 | 26/285 |
| 2022 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | Q1 | 14/136 |
| 2021 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q1 | Q1 | 12/297 |
| 2021 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | Q1 | 6/139 |
| 2020 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q1 | Q1 | 15/295 |
| 2020 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | Q1 | 5/140 |
| 2019 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q1 | Q1 | 25/297 |
| 2019 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | Q1 | 7/139 |
| 2018 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q1 | Q1 | 26/299 |
| 2018 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | Q1 | 9/136 |
| 2017 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q1 | Q1 | 29/293 |
| 2017 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | Q1 | 9/133 |
| 2016 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q1 | — | 41/290 |
| 2016 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | — | 12/128 |
| 2015 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q1 | — | 13/289 |
| 2015 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | — | 6/124 |
| 2014 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q1 | — | 12/290 |
| 2014 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | — | 6/123 |
| 2013 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q1 | — | 17/291 |
| 2013 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | — | 6/124 |
| 2012 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q1 | — | 13/290 |
| 2012 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | — | 6/121 |
| 2011 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q1 | — | 14/290 |
| 2011 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | — | 7/112 |
| 2010 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q1 | — | 10/286 |
| 2010 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | — | 4/106 |
| 2009 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q1 | — | 33/283 |
| 2009 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | — | 5/93 |
| 2008 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q1 | — | 26/275 |
| 2008 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | — | 5/83 |
| 2007 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q1 | — | 26/263 |
| 2007 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | — | 4/81 |
| 1998 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q4 | — | 259/295 |
| 1998 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 46/72 |
| 1997 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q2 | — | 111/253 |
| 1997 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | — | 16/61 |